Liu H, Wang S, Wang J, Guo X, Song Y, Fu K
Signal Transduct Target Ther. 2025; 10(1):69.
PMID: 39966374
PMC: 11836267.
DOI: 10.1038/s41392-025-02141-x.
Li G, Chen B, Sun W, Liu Z
Cogn Neurodyn. 2025; 19(1):38.
PMID: 39926335
PMC: 11799466.
DOI: 10.1007/s11571-025-10221-5.
Yi Y, Kim B, Kim M, Ko Y, Kim J, Lim M
Chem Sci. 2025; 16(10):4366-4373.
PMID: 39911331
PMC: 11793109.
DOI: 10.1039/d4sc08771b.
Sehra N, Parmar R, Jain R
RSC Med Chem. 2025; .
PMID: 39882170
PMC: 11773382.
DOI: 10.1039/d4md00729h.
Zagol-Ikapitte I, Tabatabai M, Wilus D, Alcendor D
J Clin Med. 2025; 14(2).
PMID: 39860641
PMC: 11766246.
DOI: 10.3390/jcm14020635.
Multi-target-directed therapeutic strategies for Alzheimer's disease: controlling amyloid-β aggregation, metal ion homeostasis, and enzyme inhibition.
Yoo J, Lee J, Ahn B, Han J, Lim M
Chem Sci. 2025; 16(5):2105-2135.
PMID: 39810997
PMC: 11726323.
DOI: 10.1039/d4sc06762b.
Cobalt(II) Aqua Complex-Mediated Hydrogen Peroxide Activation: Possible Roles of HOOOH and Co(II)-OOOH Intermediates in Singlet Oxygen Generation.
Chen H, Lin Y
Inorg Chem. 2024; 64(1):554-562.
PMID: 39721979
PMC: 11734112.
DOI: 10.1021/acs.inorgchem.4c03966.
Bifunctional Copper Chelators Capable of Reducing Aβ Aggregation and Aβ-Induced Oxidative Stress.
Krasnovskaya O, Abramchuk D, Vaneev A, Gorelkin P, Abakumov M, Timoshenko R
ACS Omega. 2024; 9(43):43376-43384.
PMID: 39493999
PMC: 11525521.
DOI: 10.1021/acsomega.4c03152.
A cocktail of Cu- and Zn-peptoid-based chelators can stop ROS formation for Alzheimer's disease therapy.
Behar A, Maayan G
Chem Sci. 2024; .
PMID: 39464602
PMC: 11503657.
DOI: 10.1039/d4sc04313h.
Tau‑targeting multifunctional nanocomposite based on tannic acid-metal for near-infrared fluorescence/magnetic resonance bimodal imaging-guided combinational therapy in Alzheimer's disease.
Gu Y, Zhang Q, Huang H, Ho K, Zhang Y, Yi C
Theranostics. 2024; 14(16):6218-6235.
PMID: 39431022
PMC: 11488108.
DOI: 10.7150/thno.98462.
Urolithin a Improves Motor Dysfunction Induced by Copper Exposure in SOD1 Transgenic Mice Via Activation of Mitophagy.
Zhang H, Gao C, Yang D, Nie L, He K, Chen C
Mol Neurobiol. 2024; .
PMID: 39292338
DOI: 10.1007/s12035-024-04473-1.
A biomimetic upconversion nanoreactors for near-infrared driven H release to inhibit tauopathy in Alzheimer's disease therapy.
Zhang Q, Li C, Yin B, Yan J, Gu Y, Huang Y
Bioact Mater. 2024; 42:165-177.
PMID: 39280581
PMC: 11402069.
DOI: 10.1016/j.bioactmat.2024.08.029.
Interface potential-induced natural antioxidant mimic system for the treatment of Alzheimer's disease.
Liu K, Ding Q, Cao D, Xi E, Zhao Y, Gao N
Commun Chem. 2024; 7(1):206.
PMID: 39271821
PMC: 11399259.
DOI: 10.1038/s42004-024-01299-9.
Trolox, Ferulic, Sinapic, and Cinnamic Acid Derivatives of Proline and GABA with Antioxidant and/or Anti-Inflammatory Properties.
Papagiouvannis G, Theodosis-Nobelos P, Rekka E
Molecules. 2024; 29(16).
PMID: 39202843
PMC: 11356873.
DOI: 10.3390/molecules29163763.
Phenylstyrylpyrimidine derivatives as potential multipotent therapeutics for Alzheimer's disease.
Devi B, Jangid K, Kumar V, Arora T, Kumar N, Dwivedi A
RSC Med Chem. 2024; 15(8):2922-2936.
PMID: 39149109
PMC: 11324047.
DOI: 10.1039/d4md00277f.
2-Phenylbenzothiazolyl iridium complexes as inhibitors and probes of amyloid β aggregation.
Terpstra K, Huang Y, Na H, Sun L, Gutierrez C, Yu Z
Dalton Trans. 2024; 53(34):14258-14264.
PMID: 39129539
PMC: 11445708.
DOI: 10.1039/d4dt01691b.
Unveiling the potential of novel indol-3-yl-phenyl allylidene hydrazine carboximidamide derivatives as AChE/BACE 1 dual inhibitors: a combined , synthesis and study.
Sharma A, Rudrawar S, Sharma A, Bharate S, Jadhav H
RSC Adv. 2024; 14(33):23853-23872.
PMID: 39081657
PMC: 11287240.
DOI: 10.1039/d4ra04315d.
A Multipurpose Metallophore and Its Copper Complexes with Diverse Catalytic Antioxidant Properties to Deal with Metal and Oxidative Stress Disorders: A Combined Experimental, Theoretical, and Study.
Menezes L, Sampaio R, Meurer L, Szpoganicz B, Cervo R, Cargnelutti R
Inorg Chem. 2024; 63(32):14827-14850.
PMID: 39078252
PMC: 11323273.
DOI: 10.1021/acs.inorgchem.4c00232.
Ceanothanes Derivatives as Peripheric Anionic Site and Catalytic Active Site Inhibitors of Acetylcholinesterase: Insights for Future Drug Design.
Pastene-Burgos S, Munoz-Nunez E, Quiroz-Carreno S, Pastene-Navarrete E, Espinoza Catalan L, Bustamante L
Int J Mol Sci. 2024; 25(13).
PMID: 39000410
PMC: 11242892.
DOI: 10.3390/ijms25137303.
An insight into the concept of neuroinflammation and neurodegeneration in Alzheimer's disease: targeting molecular approach Nrf2, NF-κB, and CREB.
Bhardwaj S, Grewal A, Singh S, Dhankar V, Jindal A
Inflammopharmacology. 2024; 32(5):2943-2960.
PMID: 38951436
DOI: 10.1007/s10787-024-01502-2.